Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease

Not yet recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

December 20, 2024

Primary Completion Date

November 20, 2025

Study Completion Date

December 20, 2025

Conditions

Non Alcholic Fatty Liver DiseaseHepatic SteatosisHepatic FibrosisNAFLD (Nonalcoholic Fatty Liver Disease)

All Listed Sponsors

lead

Assiut University

OTHER

NCT06739486 - Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease | Biotech Hunter | Biotech Hunter